Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
BrightSpring Health Services · Partnership · October 6, 2026
BeOne Medicines selected Onco360 as a specialty pharmacy partner for Beqalzi (sonrotoclax), a treatment for adults with relapsed or refractory mantle cell lymphoma.
AntSpace’s summary of BrightSpring Health Services’s own announcement: read the original.